Benchmarking Deep Learning for Future Liver Remnant Segmentation in Colorectal Liver Metastasis

While colorectal liver metastasis (CRLM) is potentially curable via hepatectomy, patient outcomes remain highly heterogeneous. Postoperative survival prediction is necessary to avoid non-beneficial surgeries and guide personalized therapy. In this study, we present an automated AI-based framework for postoperative CRLM survival prediction using pre- and post-contrast MRI. We performed a retrospective study of 227 CRLM patients who had gadoxetate-enhanced MRI prior to curative-intent hepatectomy between 2013 and 2020. We developed a survival prediction framework comprising an anatomy-aware segmentation pipeline followed by a radiomics pipeline. The segmentation pipeline learns liver, CRLMs, and spleen segmentation from partially-annotated data, leveraging promptable foundation models to generate pseudo-labels. To support this pipeline, we propose SAMONAI, a prompt propagation algorithm that extends Segment Anything Model to 3D point-based segmentation. Predicted pre- and post-contrast segmentations are then fed into our radiomics pipeline, which extracts per-tumor features and predicts survival using SurvAMINN, an autoencoder-based multiple instance neural network for time-to-event survival prediction. SurvAMINN jointly learns dimensionality reduction and survival prediction from right-censored data, emphasizing high-risk metastases. We compared our framework against established methods and biomarkers using univariate and multivariate Cox regression. Our segmentation pipeline achieves median Dice scores of 0.96 (liver) and 0.93 (spleen), driving a CRLM segmentation Dice score of 0.78 and a detection F1-score of 0.79. Accurate segmentation enables our radiomics pipeline to achieve a survival prediction C-index of 0.69. Our results show the potential of integrating segmentation algorithms with radiomics-based survival analysis to deliver accurate and automated CRLM outcome prediction.

Accurate segmentation of colorectal liver metastases (CRLM) in contrast-enhanced computed tomography (CT) is important for response assessment, surgical planning, and follow-up. We propose two parameter-efficient spectral adapters for the Segment Anything Model (SAM): the Directional Spectral Adapter (DiSECT) and Spectral Instance-Guided Adapter (SiGA). DiSECT uses singular value decomposition of frozen weights to constrain residual updates to leading spectral directions, while SiGA adds global and input-conditioned gating through a multilayer perceptron. We evaluate these methods on 446 contrast-enhanced CT volumes (355 training, 91 testing) and compare them with LoRA, QLoRA, convolutional adapters (CAD), and a 3D nnU-Net baseline. Experiments consider single-point, three-point, bounding-box, and no-prompt regimes. SiGA achieves the best single-point performance with a Dice score of 0.77, IoU of 0.69, and HD95 of 35.39 mm. Under no-prompt inference, SiGA reaches 0.76 Dice, 0.68 IoU, and 46.76 mm HD95, comparable to the nnU-Net baseline (0.758 Dice). DiSECT uses only 0.14 million trainable parameters. These results show that spectral adapters can efficiently adapt SAM for CRLM segmentation while retaining strong accuracy with limited trainable parameters.

Automated segmentation of liver lesions on non-contrast computed tomography (NCCT) is clinically important but fundamentally challenging, particularly in low-resource settings across Africa and Asia where contrast agents are frequently unavailable. Progress has been limited by the absence of annotated NCCT benchmarks. Here we describe the TriALS challenge for automated liver lesion segmentation under contrast-limited conditions, supported by a multi-centre dataset of 150 cases with four-phase CT acquisitions (600 volumes) from Egyptian and Chinese institutions. Algorithms were evaluated on 70 cases from three institutions, including an independent external cohort. The top-performing method achieved a mean venous-phase Dice of 0.754, consistent with human-level performance, yet dropped to 0.57 on NCCT. On external validation, the leading method outperformed off-the-shelf models by up to 28% in Dice on NCCT. Algorithm performance was most strongly predicted by training data scale and pre-training strategy. A cross-year comparison exposed a persistent perceptual barrier on NCCT that scaling pre-training alone cannot overcome. Data, annotations, and code are available at https://github.com/xmed-lab/TriALS.